Nangibotide in patients with septic shock: a Phase 2a randomized controlled clinical trial.
François B, Wittebole X, Ferrer R, Mira JP, Dugernier T, Gibot S, Derive M, Olivier A, Cuvier V, Witte S, Pickkers P, Vandenhende F, Garaud JJ, Sánchez M, Salcedo-Magguilli M, Laterre PF.
François B, et al. Among authors: witte s.
Intensive Care Med. 2020 Jul;46(7):1425-1437. doi: 10.1007/s00134-020-06109-z. Epub 2020 May 28.
Intensive Care Med. 2020.
PMID: 32468087
Clinical Trial.